640 related articles for article (PubMed ID: 18310202)
1. Improving pediatric dosing through pediatric initiatives: what we have learned.
Rodriguez W; Selen A; Avant D; Chaurasia C; Crescenzi T; Gieser G; Di Giacinto J; Huang SM; Lee P; Mathis L; Murphy D; Murphy S; Roberts R; Sachs HC; Suarez S; Tandon V; Uppoor RS
Pediatrics; 2008 Mar; 121(3):530-9. PubMed ID: 18310202
[TBL] [Abstract][Full Text] [Related]
2. Adolescent dosing and labeling since the Food and Drug Administration Amendments Act of 2007.
Momper JD; Mulugeta Y; Green DJ; Karesh A; Krudys KM; Sachs HC; Yao LP; Burckart GJ
JAMA Pediatr; 2013 Oct; 167(10):926-32. PubMed ID: 23921678
[TBL] [Abstract][Full Text] [Related]
3. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients--FDA. Final rule.
Fed Regist; 1998 Dec; 63(231):66631-72. PubMed ID: 10338880
[TBL] [Abstract][Full Text] [Related]
4. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies.
Roberts R; Rodriguez W; Murphy D; Crescenzi T
JAMA; 2003 Aug; 290(7):905-11. PubMed ID: 12928467
[TBL] [Abstract][Full Text] [Related]
5. New pediatric dosage rules: information and testing.
Feeg VD
Pediatr Nurs; 1998; 24(6):518, 613. PubMed ID: 10085992
[No Abstract] [Full Text] [Related]
6. Optimizing pediatric dosing: a developmental pharmacologic approach.
Anderson GD; Lynn AM
Pharmacotherapy; 2009 Jun; 29(6):680-90. PubMed ID: 19476420
[TBL] [Abstract][Full Text] [Related]
7. The march toward rational therapeutics in children.
Gorman RL
Pediatr Infect Dis J; 2003 Dec; 22(12):1119-23. PubMed ID: 14688584
[TBL] [Abstract][Full Text] [Related]
8. Extrapolation of adult data and other data in pediatric drug-development programs.
Dunne J; Rodriguez WJ; Murphy MD; Beasley BN; Burckart GJ; Filie JD; Lewis LL; Sachs HC; Sheridan PH; Starke P; Yao LP
Pediatrics; 2011 Nov; 128(5):e1242-9. PubMed ID: 22025597
[TBL] [Abstract][Full Text] [Related]
9. Advances in pediatric pharmacology, therapeutics, and toxicology.
Berlin CM
Adv Pediatr; 2001; 48():439-64. PubMed ID: 11480767
[TBL] [Abstract][Full Text] [Related]
10. Criteria supporting the study of drugs in the newborn.
Ward RM; Benitz WE; Benjamin DK; Blackmon L; Giacoia GP; Hudak M; Lasky T; Rodriguez W; Selen A
Clin Ther; 2006 Sep; 28(9):1385-98. PubMed ID: 17062311
[TBL] [Abstract][Full Text] [Related]
11. Dosing considerations in the pediatric patient.
Skaer TL
Clin Ther; 1991; 13(5):526-44; discussion 525. PubMed ID: 1799910
[TBL] [Abstract][Full Text] [Related]
12. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
13. Applications of population pharmacokinetics in current drug labelling.
Duan JZ
J Clin Pharm Ther; 2007 Feb; 32(1):57-79. PubMed ID: 17286790
[TBL] [Abstract][Full Text] [Related]
14. Off-label or off-limits?
Ritchey ML
J Urol; 2013 Jul; 190(1):8-9. PubMed ID: 23608037
[No Abstract] [Full Text] [Related]
15. Stimulation programs for pediatric drug research--do children really benefit?
Boots I; Sukhai RN; Klein RH; Holl RA; Wit JM; Cohen AF; Burggraaf J
Eur J Pediatr; 2007 Aug; 166(8):849-55. PubMed ID: 17225950
[TBL] [Abstract][Full Text] [Related]
16. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
[TBL] [Abstract][Full Text] [Related]
17. Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia.
Läer S; Elshoff JP; Meibohm B; Weil J; Mir TS; Zhang W; Hulpke-Wette M
J Am Coll Cardiol; 2005 Oct; 46(7):1322-30. PubMed ID: 16198851
[TBL] [Abstract][Full Text] [Related]
18. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.
Novak E; Allen PJ
Pediatr Nurs; 2007; 33(1):64-70. PubMed ID: 17411005
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological research in pediatrics: From neonates to adolescents.
Rakhmanina NY; van den Anker JN
Adv Drug Deliv Rev; 2006 Apr; 58(1):4-14. PubMed ID: 16533543
[TBL] [Abstract][Full Text] [Related]
20. The economics of pediatric formulation development for off-patent drugs.
Milne CP; Bruss JB
Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
